ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,592.90
-2.06%
S&P ASX All Technology
2,931.30
-1.81%
Brent Oil
90.04
0.18%
US Dollar vs AUD
1.55927
0.45%
Bitcoin
63,058.39
-0.58%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vir Biotechnology Inc (VIR)

  7. Vir Biotechnology Inc (VIR) News

VIR Vir Biotechnology Inc

8.55
-0.42 (-4.68%)
16 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Vir Biotechnology Inc VIR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.42 -4.68% 8.55 10:00:00
Open Price Low Price High Price Close Price Previous Close
8.97 8.44 8.985 8.57 8.97
more quote information »

Recent News

Date Time Source Heading
12/4/202406:30BWVir Biotechnology to Provide Business Update and Report..
06/3/202400:05BWVir Biotechnology Completes Enrollment of Phase 2 Chronic..
27/2/202411:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202411:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202411:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202411:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202408:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202408:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
24/2/202400:05BWVir Biotechnology to Participate in Upcoming Investor..
23/2/202408:12EDGAR2Form 8-K - Current report
23/2/202408:05BWVir Biotechnology Provides Corporate Update and Reports..
21/2/202408:33EDGAR2Form 8-K - Current report
21/2/202408:30BWVir Biotechnology Announces Dr. Phil Pang Will Step Down as..
17/2/202410:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202409:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202408:05BWVir Biotechnology to Provide Business Update and Report..
04/1/202406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202321:59IHMARKETNEWSApple Stocks Reach Record, Adobe Faces Stock Drops,..
14/12/202308:06EDGAR2Form 8-K - Current report
14/12/202308:05BWVir Biotechnology Announces Strategic Steps to Reduce..
07/12/202308:05BWVir Biotechnology to Present at J.P. Morgan 2024 42nd Annual..
14/11/202300:00BWVir Biotechnology to Present New Data from Its Ongoing Phase..
11/11/202300:00BWVir Biotechnology to Present Late-Breaking Data from Its..
09/11/202300:05BWVir Biotechnology Ranked the Fastest-Growing Company in..
04/11/202307:37EDGAR2Form 8-K - Current report
04/11/202307:33EDGAR2Form S-3ASR - Automatic shelf registration statement of..
04/11/202307:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202307:09EDGAR2Form 8-K - Current report
03/11/202307:05BWVir Biotechnology Provides Corporate Update and Reports..
30/10/202323:00BWVir Biotechnology Appoints Jennifer Towne, Ph.D., as..
13/10/202307:05GLOBEVir Biotechnology to Participate in the H.C. Wainwright 4th..
11/10/202323:00GLOBEVir Biotechnology Announces Multiple Abstracts Highlighting..
06/10/202307:30GLOBEVir Biotechnology to Provide Business Update and Report..
03/10/202323:01EDGAR2Form 8-K - Current report
03/10/202322:59GLOBEVir Biotechnology Awarded BARDA Funding to Support..
20/9/202322:00GLOBEVir Biotechnology Announces First Participant Dosed in New..
20/9/202320:02EDGAR2Form 8-K - Current report
30/8/202306:30GLOBEVir Biotechnology to Participate in Upcoming Investor..
05/8/202306:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202306:14EDGAR2Form 8-K - Current report
04/8/202306:05GLOBEVir Biotechnology Provides Corporate Update and Reports..
27/7/202306:05GLOBEVir Biotechnology to Provide Business Update and Report..
20/7/202322:04EDGAR2Form 8-K - Current report
20/7/202322:00GLOBEVir Biotechnology Announces Topline Data from Phase 2..
06/7/202311:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/7/202311:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202307:01EDGAR2Form 144 - Report of proposed sale of securities
29/6/202323:00GLOBEVir Biotechnology Appoints Sasha Damouni Ellis as Executive..
24/6/202319:30GLOBEVir Biotechnology Presents New Data Evaluating the Potential..
07/6/202316:13GLOBEVir Biotechnology Announces Multiple Abstracts Highlighting..

Your Recent History

NASDAQ
VIR
Vir Biotechnology
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved